Recurrent infections and immune evasion strategies of Staphylococcus aureus

Hwan Keun Kim1, Vilasack Thammavongsa, Olaf Schneewind

  • 1Department of Microbiology, University of Chicago, Chicago, IL 60637, United States.

Insights

Staphylococcus aureus evades the immune system using secreted proteins like SpA, Sbi, and AdsA. Understanding these immune evasion strategies is key to developing effective vaccines and treatments for staphylococcal infections.

Area of Science:

  • Microbiology
  • Immunology
  • Infectious Diseases

Background:

  • Staphylococcus aureus causes recurrent skin and soft tissue infections (SSTIs), leading to invasive disease and sepsis.
  • Staphylococcal infections do not induce protective immunity, posing a significant global health challenge.
  • Effective treatments are limited due to the pathogen's ability to evade immune responses.

Purpose of the Study:

  • To review the immune evasive strategies employed by Staphylococcus aureus.
  • To detail the roles of three key secreted products: staphylococcal protein A (SpA), staphylococcal binder of immunoglobulin (Sbi), and adenosine synthase A (AdsA).
  • To explore potential therapeutic and vaccine development avenues based on these evasion mechanisms.

Main Methods:

  • Review of existing literature on Staphylococcus aureus virulence factors and immune evasion.
  • Detailed analysis of the molecular mechanisms of SpA, Sbi, and AdsA in subverting host immunity.
  • Discussion of potential applications for vaccine and therapeutic strategies.

Main Results:

  • SpA modulates antibody responses by acting as a superantigen and binding pathogen-specific antibodies.
  • Sbi binds complement factors, promoting complement system depletion.
  • AdsA synthesizes adenosine, suppressing innate and adaptive immune responses.

Conclusions:

  • SpA, Sbi, and AdsA are critical secreted factors enabling Staphylococcus aureus immune evasion.
  • Targeting these secreted products offers promising strategies for novel vaccines and therapeutics.
  • Further research into these mechanisms can lead to improved control of staphylococcal infections.

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...